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Biofilms are structured communities of bacteria that adhere to surfaces and shield bacteria from hostile 
environments. They are a major problem in healthcare, accounting for an estimated 80% of human infections. 
Biofilms are inherently resistant to both antibiotics and host defense mechanisms. Thus, existing treatments 
often fail to eradicate biofilms resulting in chronic infections. We are working to develop enzyme-based 
therapeutics to prevent and/or disrupt biofilm formation. Our enzymes target a bacterial signalling system called 
quorum sensing. It is a precursor process to biofilm formation for many clinically relevant bacterial pathogens. 
The disruption of this signalling –“quorum quenching” – is a promising new approach for preventing biofilm 
formation. Many Gram-negative bacteria, including Pseudomonas aeruginosa, Burkholderia and Acinetobacter 
species, use acyl-homoserine lactones (AHLs) as signals for quorum sensing. We are engineering acylase 
enzymes to degrade these signalling molecules. Native acylases degrade AHLs by irreversibly cleaving them 
into their fatty acid and homoserine lactone products. However, the few AHL acylases characterised to date 
have poor heterologous expression, low yields and limited substrate specificity. To overcome this, I am using a 
highly expressed, well-characterised acylase to engineer quorum-quenching enzymes. While this acylase acts 
on different substrates to AHL acylases, the catalytic residues are conserved, and they share a similar structure. 
To date, I have made 630 variants using rational design and directed evolution, and have identified 2 mutants 
with activity towards AHLs using a high-throughput screen. Characterisation of the wild-type and variant 
enzymes will be presented. 
 
